ConductScience.org, home

Paper3300518

Clonidine and Gilles de la Tourette's syndrome: double-blind study using objective rating methods.

Goetz CG and 5 others. Ann Neurol, 1987. Cited by 114 papers, by iCite.

Cite this record

ConductScience Library. Clonidine and Gilles de la Tourette's syndrome: double-blind study using objective rating methods. Papers, record 3300518. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3300518

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clonidine and Gilles de la Tourette's syndrome: double-blind study using objective rating methods.
PubMed
Journal
Ann Neurol
PubMed
Year
1987
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
114
iCite
Relative citation ratio, by iCite
5.55
iCite
Revised in PubMed
2022-04-08
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Goetz CGC G
2Tanner CMC M
3Wilson RSR S
4Carroll VSV S
5Como PGP G
6Shannon KMK M

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ClonidineMajor topic
Tourette SyndromeMajor topic
Adolescent
Adult
Child
Clinical Trials as Topic
Double-Blind Method
Female
Humans
Male
Middle Aged
Random Allocation

Source PubMed

Download CSV of topics

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 114 citations.

PMIDTitleJournalYearIn PapersSource
37962703Pharmacological treatment of Tourette's syndrome: from the past to the future.Neurol Sci2024https://conductscience.org/library/papers/37962703PubMed
35107785Tourette Syndrome Treatment Updates: a Review and Discussion of the Current and Upcoming Literature.Curr Neurol Neurosci Rep2022https://conductscience.org/library/papers/35107785PubMed
34547532Pharmacological therapy for Tourette syndrome: What medicine can do and cannot do.Biomed J2022https://conductscience.org/library/papers/34547532PubMed
33658970Thalamic Local Field Potentials Are Related to Long-Term DBS Effects in Tourette Syndrome.Front Neurol2021https://conductscience.org/library/papers/33658970PubMed
32457692Effectiveness and Safety of a Clonidine Adhesive Patch for Children With Tic Disorders: Study in a Real-World Practice.Front Neurol2020https://conductscience.org/library/papers/32457692PubMed
30899317Guanfacine monotherapy for ADHD/ASD comorbid with Tourette syndrome: a case report.Ann Gen Psychiatry2019https://conductscience.org/library/papers/30899317PubMed
30306450VMAT2 Inhibitors in Neuropsychiatric Disorders.CNS Drugs2018https://conductscience.org/library/papers/30306450PubMed
29963275Pharmacotherapies to tics: a systematic review.Oncotarget2018https://conductscience.org/library/papers/29963275PubMed
28280480The Efficacy and Tolerability of the Clonidine Transdermal Patch in the Treatment for Children with Tic Disorders: A Prospective, Open, Single-Group, Self-Controlled Study.Front Neurol2017https://conductscience.org/library/papers/28280480PubMed
21555779Behavior therapy for tics in children: acute and long-term effects on psychiatric and psychosocial functioning.J Child Neurol2011https://conductscience.org/library/papers/21555779PubMed
21445724European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.Eur Child Adolesc Psychiatry2011https://conductscience.org/library/papers/21445724PubMed
21339906Treatment strategies for tics in Tourette syndrome.Ther Adv Neurol Disord2011https://conductscience.org/library/papers/21339906PubMed
19821373Cannabinoids for Tourette's Syndrome.Cochrane Database Syst Rev2009https://conductscience.org/library/papers/19821373PubMed
19339874Assessing the validity of current mouse genetic models of obsessive-compulsive disorder.Behav Pharmacol2009https://conductscience.org/library/papers/19339874PubMed
18769586Psychopharmacology of tic disorders.J Can Acad Child Adolesc Psychiatry2008https://conductscience.org/library/papers/18769586PubMed
17726915Tourette's syndrome: clinical features, pathophysiology, and therapeutic approaches.Dialogues Clin Neurosci2007https://conductscience.org/library/papers/17726915PubMed
12930697Tourette's syndrome: are stimulants safe?Curr Neurol Neurosci Rep2003https://conductscience.org/library/papers/12930697PubMed
11898516The treatment of tics.Curr Neurol Neurosci Rep2001https://conductscience.org/library/papers/11898516PubMed
11772131Pharmacological options for the treatment of Tourette's disorder.Drugs2001https://conductscience.org/library/papers/11772131PubMed
11140781Gilles de la Tourette syndrome: symptomatic treatment based on evidence.Eur Child Adolesc Psychiatry2000https://conductscience.org/library/papers/11140781PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3300518

GET https://conductscience.org/api/papers/v1/3300518/cited_by?page=2